148 related articles for article (PubMed ID: 26909589)
1. ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin.
Xu B; Naughton D; Busam K; Pulitzer M
Am J Dermatopathol; 2016 Sep; 38(9):672-7. PubMed ID: 26909589
[TBL] [Abstract][Full Text] [Related]
2. Expression of JL1 is an effective adjunctive marker of leukemia cutis.
Park YS; Park SH; Park SJ; Kim Y; Jang KT; Ko YH; Lee MW; Huh JR; Park CS
Arch Pathol Lab Med; 2010 Jan; 134(1):95-102. PubMed ID: 20073611
[TBL] [Abstract][Full Text] [Related]
3. CD30 Expression Is Rare in Myeloid Leukemia Cutis: A Study of 55 Cases and Implications for Routine Diagnostic Algorithms.
Ogunrinade O; Terrano D; Chiu A; Pulitzer M
Am J Dermatopathol; 2017 May; 39(5):351-357. PubMed ID: 27893466
[TBL] [Abstract][Full Text] [Related]
4. Value of immunohistochemistry in the diagnosis of leukemia cutis: study of 54 cases using paraffin-section markers.
Ratnam KV; Su WP; Ziesmer SC; Li CY
J Cutan Pathol; 1992 Jun; 19(3):193-200. PubMed ID: 1383298
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of ERG immunostaining in dermatofibroma.
Yamada Y; Ichiki T; Susuki Y; Yamada-Nozaki Y; Tateishi Y; Furue M; Oda Y
J Clin Pathol; 2023 Aug; 76(8):536-540. PubMed ID: 35318257
[TBL] [Abstract][Full Text] [Related]
6. ERG Immunoreactivity in Blastic Hematolymphoid Neoplasms: Diagnostic Pitfall in the Workup of Undifferentiated Malignant Neoplasms.
Koo M; Natkunam Y
Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):42-48. PubMed ID: 34261976
[TBL] [Abstract][Full Text] [Related]
7. ERG Expression is Helpful in Differentiating T-Lymphoblastic Lymphoma from Thymoma.
Huang W; Zhang W; Zeng L; Liao S; Liu F; Li L
Int J Surg Pathol; 2023 Apr; 31(2):137-141. PubMed ID: 35435050
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
9. Myeloid leukemia cutis: a histologic and immunohistochemical review.
Cibull TL; Thomas AB; O'Malley DP; Billings SD
J Cutan Pathol; 2008 Feb; 35(2):180-5. PubMed ID: 18190442
[TBL] [Abstract][Full Text] [Related]
10. Myeloid sarcoma and extramedullary hematopoiesis expand the spectrum of ERG-positive proliferations: an ancillary tool in the diagnosis.
Vargas AC; Turner J; Burchett I; Ho LL; Zumbo R; Gill AJ; Maclean FM
Hum Pathol; 2022 Jun; 124():1-13. PubMed ID: 35307404
[TBL] [Abstract][Full Text] [Related]
11. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
[TBL] [Abstract][Full Text] [Related]
12. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases.
Sullivan HC; Edgar MA; Cohen C; Kovach CK; HooKim K; Reid MD
J Clin Pathol; 2015 Jan; 68(1):44-50. PubMed ID: 25352641
[TBL] [Abstract][Full Text] [Related]
13. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
15. Cytophagic and S-100 protein immunoreactive myeloid leukemia cutis.
Thomas CG; Patel RM; Bergfeld WF
J Cutan Pathol; 2010 Mar; 37(3):390-5. PubMed ID: 19615019
[TBL] [Abstract][Full Text] [Related]
16. CD163 expression in leukemia cutis.
Harms PW; Bandarchi B; Ma L
J Cutan Pathol; 2010 Sep; 37(9):953-7. PubMed ID: 20175823
[TBL] [Abstract][Full Text] [Related]
17. The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.
Berg KD
Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910803
[TBL] [Abstract][Full Text] [Related]
18. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.
Miettinen M; Wang ZF; Paetau A; Tan SH; Dobi A; Srivastava S; Sesterhenn I
Am J Surg Pathol; 2011 Mar; 35(3):432-41. PubMed ID: 21317715
[TBL] [Abstract][Full Text] [Related]
19. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer.
Song W; Kwon GY; Kim JH; Lim JE; Jeon HG; Il Seo S; Jeon SS; Choi HY; Jeong BC; Lee HM
Oncotarget; 2016 Dec; 7(50):83735-83743. PubMed ID: 27863438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]